UnitedHealth Group’s (UNH) stock is down almost 40% this year, pressured by public criticism over rising healthcare costs and a Justice Department investigation into its Medicare billing practices. Notably, TipRanks’ A.I. Analyst cuts UNH stock forecast, suggesting caution about its near-term potential. On the other hand, Wall Street has a Strong Buy rating on the stock.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
For context, TipRanks’ A.I. Stock Analysis delivers automated, data-driven evaluations of stocks, giving investors a clear and concise snapshot of a stock’s potential. Moreover, TipRanks’ A.I.-driven rating combines insights from multiple models, including OpenAI’s (PC:OPAIQ) GPT-4o and Perplexity’s SonarPro.
AI Analyst Downgrades UNH Stock
Today, TipRanks A.I. Analyst Soren Coverra (under the OpenAI-4o model) downgraded UNH stock from Buy to Hold. Coverra also trimmed his price target from $401 to $335, predicting a modest upside of over 7% from current levels.
According to TipRanks A.I. Stock Analysis, technical analysis shows bearish momentum, while valuation metrics indicate the stock is fairly priced. Additionally, challenges such as rising medical costs and declining membership could affect short-term performance. The A.I. Analyst believes the company’s focus on operational improvements and strategic adjustments will be key to driving future growth.
AI Analyst Breaks Down UNH Stock Outlook
TipRanks’ AI-powered stock analysis assigns UnitedHealth a score of 67 out of 100. The tool also flags key positive drivers as well as risks that could weigh on the company’s future stock performance.
Among the bullish factors, UnitedHealth benefits from strong revenue growth, reflecting solid demand. Meanwhile, healthy cash flow provides the flexibility to invest in growth and maintain a competitive edge. In Q3, the company served 50.1 million U.S. customers, up 795,000 compared with last year.
On the bearish side, the company faces challenges from declining Medicare Advantage membership, which could hurt revenue and market share. Rising medical costs continue to pressure margins, while limited Medicaid funding may strain resources and affect the company’s ability to maintain service levels, all of which could impact growth and profitability.
Wall Street Is Bullish on UNH
Among the bullish voices on Wall Street, Wells Fargo analyst Stephen Baxter recently reiterated his Buy rating on UNH with a price target of $400, signaling about 28% potential upside from current levels.
Despite recent challenges, Baxter believes UnitedHealth holds a strong position in employer-sponsored and government-backed insurance, with more than 50 million members worldwide, making it a stock worth holding.
Is UNH a Good Buy Right Now?
Overall, Wall Street analysts remain bullish on UNH stock. According to TipRanks’ consensus, UNH stock has a Strong Buy consensus rating based on 17 Buys, three Holds, and one Sell assigned in the last three months. At $393.95, the average UnitedHealth stock price target implies a 26.5% upside potential.
